Comparison of Oxygen Adminstration by Nasal Cannula and High Flow Cannula During Bronchoscopy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

108 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-11-10

Study Completion Date

2019-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Randomized controled trial to compare oxygen desaturation during fiberoptic bronchoscopy using oxygen administered with nasal prongs and high flow nasal cannula. Drops in oxygen saturation are frequent during bronchoscopy and limit the procedure compromising patient security. The investigator's aim is to contribute to select better way of oxygen administration which could prevent desaturations during bronchoscopy in children.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

High Flow Nasal Cannula Use in Infants With Bronchiolitis

NCT02737280

Bronchiolitis

TERMINATED NA

Study of High-flow Oxygen Therapy Against Standard Therapy in Bronchiolitis

NCT01498094

Bronchiolitis

COMPLETED NA

Optimizing High Flow Nasal Cannula Oxygenation in Pediatric Airway Procedures

NCT06947902

Airway Disorder

NOT_YET_RECRUITING NA

High Flow Nasal Cannula Rates in Pediatric Asthma

NCT06379607

Pediatric Asthma

ENROLLING_BY_INVITATION NA

The Effects of High-flow Nasal Oxygen on Oxygenation During Rigid Bronchoscopy Under General Anesthesia in Pediatric Patients

NCT03905733

Foreign Bodies Tumor Stenosis of Trachea +1 more

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Common nasal cannula

Oxygen administration up to 4 liters according defined protocol

Group Type ACTIVE_COMPARATOR

Oxygen administration with Common nasal cannula

Intervention Type DEVICE

Oxygen administration during elective flexible bronchoscopy in children with high flow nasal cannula with inspired oxygen fraction 1.

High flow nasal cannula

Oxygen administered with high flow nasal cannula according child weight and protocol designed for this study

Group Type EXPERIMENTAL

Oxygen administration with high flow nasal cannula, device Airvo2 Fisher and Pykel

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Oxygen administration with Common nasal cannula

Oxygen administration during elective flexible bronchoscopy in children with high flow nasal cannula with inspired oxygen fraction 1.

Intervention Type DEVICE

Oxygen administration with high flow nasal cannula, device Airvo2 Fisher and Pykel

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* elective flexible bronchoscopy

Exclusion Criteria

* admitted in Neonatal intensive care
* previous respiratory support: oxygen any device, non invasive or invasive ventilation
* patient who may benefit with continuous positive pressure during procedure

Minimum Eligible Age

29 Days

Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No